Drugs / 732461
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00972725 | Dec 2009 → Oct 2010 | AIDS | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 732461 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00972725 ↗ |
| Known as | F4/AS01(B) | “This phase II study evaluated the effect of chloroquine on the specific CD8(+) T-cell responses to and the safety of a booster dose of investigational human immunodeficiency...” PMID 24391139 ↗ Jan 2014 |
| Modality | Vaccine | “investigational human immunodeficiency virus type 1 (HIV-1) F4/AS01(B) vaccine” PMID 24391139 ↗ Jan 2014 |
| Route | Intramuscular | “1 dose intramuscular injection” NCT00972725 ↗ |